GT Biopharma Inc (GTBP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.47
• Market Cap: $12.44M
• EPS: $-3.50
• 52-Week High: $3.85
• 52-Week Low: $0.40

Market Sentiment

GT Biopharma Inc currently has a Bullish sentiment score of 0.20.

About GT Biopharma Inc

GT Biopharma Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology therapies, utilizing its proprietary Tri-specific Killer Engager (TriKE) technology platform to enhance immune responses against cancer. Headquartered in Beverly Hills, California, the company is dedicated to addressing critical unmet medical needs in oncology, with a robust pipeline designed to empower the immune system in targeting and eliminating malignant cells. As it p...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for GT Biopharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GTBP pay dividends?

GT Biopharma Inc (GTBP) does not currently pay a regular dividend.

What is GTBP's market cap?

GT Biopharma Inc (GTBP) has a market capitalization of $12.44M with a current stock price of $0.47.